Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Round spermatid basic protein 1 (RSBN1) is a histone demethylase, also known as KDM9, that primarily removes methyl groups from dimethylated and trimethylated lysine 20 on histone H4 (H4K20me2/3), thereby modulating chromatin structure and contributing to epigenetic regulation during sperm cell development[1][2][4]. RSBN1 is expressed predominantly in round and elongated spermatids but is also found in brain and ovary tissue[1]. The demethylation function of RSBN1 is critical for chromosome architecture and genome stability in germ cells, making it important for proper meiotic progression, though it is not considered a direct therapeutic target nor associated with specific diseases[1]. Alternative names for RSBN1 include KDM9, FLJ11220, and ROSBIN[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Round spermatid basic protein 1 (RSBN1).